STTR Phase I: Oral Cancer Detection Using Redox Magnetohydrodynamic Microfluidics-based Bioassay Chips

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$150,000.00
Award Year:
2007
Program:
STTR
Phase:
Phase I
Contract:
0712204
Agency Tracking Number:
0712204
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
SFC Fluidics, LLC
535 W RESEARCH BLVD, SUITE 135,, 6745 HOLLISTER AVENUE, FAYETTEVILLE, AR, 72701
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
125518428
Principal Investigator:
Christine Evans
Dr
(479) 571-2592
ceevans@sfc-fluidics.com
Business Contact:
Mark Wagstaff
PhD
(479) 571-2592
mwagstaff@virtual-incubation.com
Research Institution:
Univ of PA School of Medicine
Barry L Ziober
3451 Walnut St, P221 Franklin
Philadelphia, PA, 19104-6205
(215) 898-7293
Nonprofit college or university
Abstract
This Small Business Technology Transfer Research (STTR) Phase I project aims to develop a molecular signature-based redox magnetohydrodynamic (MHD) microfluidic system for the detection of oral cancer. The microfluidic chips are expected to interface with a handheld readout instrument that has a low operator skill requirement and is suited for point-of-care operation.If successful, the methodology can be used for early detection of oral squamous cell carcinoma, as well as other forms of cancer and as such may benefit a large number of individuals suffering from cancer.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government